Purchase Order HT001423P0154
Award Date 7/24/23
Potential Completion Date 5/1/24
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $47,053.56 firm fixed price purchase order to LGC Clinical Diagnostics Inc. on September 27, 2024, for calibration verification and linearity test kits for cardiac equipment and Maine standard reagents. The contract, with an ultimate completion date of March 22, 2025, carries no set-aside designation and will be performed in Italy. LGC Clinical Diagnostics Inc., a Massachusetts-based clinical diagnostics manufacturer and child entity within a larger...
- The Defense Health Agency awarded Diasorin Inc. a delivery order valued at $61,602.00 for LIAISON MDX supply kits, with an ultimate completion date of September 30, 2026. This contract reflects Diasorin's ongoing role as a specialized supplier of diagnostic testing equipment and related supplies to federal healthcare agencies. As a foreign-owned subsidiary of Italian-based Diasorin S.P.A., the company has established itself as a key provider of chemiluminescence immunoassay analyzers,...
- Laboratory Corporation of America has been awarded a $2.25 million firm fixed price delivery order against an unspecified government-wide acquisition contract (GWAC) by the Defense Health Agency to provide clinical reference laboratory testing services. The prime contractor will perform the testing out of its Portsmouth, Virginia laboratory location from April 1, 2021 through September 30, 2021. No subcontractors or set aside designations were identified. The Defense Health Agency is a joint,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc. for $24,778.00. The contract is for the delivery of SeraCare bioservices, which include quality control tools, reference materials, controls, reagents, and biological materials to support clinical diagnostics, disease prevention, and health promotion initiatives. LGC Clinical Diagnostics, a foreign-owned, for-profit manufacturer, has been awarded...
- The Defense Health Agency awarded a $11,679.19 delivery order to Diatec - S.R.L., an Italian medical supply vendor, on February 23, 2024, with a completion date of March 1, 2024. This delivery order procures reagents compatible with Vitros 5600, 350, and XT7600 diagnostic analyzers—laboratory equipment used for clinical testing and medical diagnostics at U.S. military medical facilities. The contract employs firm fixed price pricing with no set-aside designation and was awarded on a full and...
- Laboratory Corporation of America has been awarded a $5.25 million firm fixed price delivery order against an unidentified contract vehicle by the Defense Health Agency to provide clinical reference laboratory testing services. The services will be performed in Portsmouth, Virginia over a one year period ending in September 2022. No set aside designation or subcontracting details are provided in the award information. The Defense Health Agency is a joint agency that manages the Military Health...
- This federal contract award is for the validation of the new Roche Instruments, COBAS 5800 (R) diagnostic equipment to LGC Clinical Diagnostics, Inc., a foreign-owned, for-profit manufacturer of clinical diagnostic products and reference materials. The $18,840.40 firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, with an ultimate completion date of October 2, 2025. The contract does not have a set-aside designation....
- The Defense Health Agency awarded a Liaison MDX Service purchase order to Diasorin Molecular, LLC valued at $31,902.78 on January 23, 2023, with performance scheduled to conclude on January 22, 2027. This firm fixed-price contract, issued without set-aside designation, will be performed at Joint Base Lewis-McChord in Washington State. Diasorin Molecular, a foreign-owned manufacturer of molecular diagnostic products headquartered in Cypress, California, will provide Liaison MDX diagnostic...
- The Defense Health Agency awarded a delivery order valued at $105,482.93 to Diasorin Inc. for LIAISON XL test kits, supplies, and analyzer use, with performance concluding on September 30, 2025. This delivery order represents a firm fixed price procurement with no socioeconomic set-aside designation and will be performed at Lewis-McChord, Washington. Diasorin Inc., a Minnesota-based subsidiary of Italian parent company Diasorin S.P.A., is a specialized medical diagnostics firm that...